📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML. (2024)

First Author: Risueño A

Attributed to: Biology and Treatment of Human Myeloid Cancers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.leukres.2024.107497

PubMed Identifier: 38564986

Publication URI: http://europepmc.org/abstract/MED/38564986

Type: Journal Article/Review

Volume: 140

Parent Publication: Leukemia research

ISSN: 0145-2126